Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Nonpituitary tumors of the sellar region].
Czepielewski MA, Rollin GA, Casagrande A, Ferreira MP, Ferreira NP. Czepielewski MA, et al. Among authors: casagrande a. Arq Bras Endocrinol Metabol. 2005 Oct;49(5):674-90. doi: 10.1590/s0004-27302005000500008. Epub 2006 Jan 23. Arq Bras Endocrinol Metabol. 2005. PMID: 16444350 Review. Portuguese.
Criteria of cure and remission in Cushing's disease: an update.
Czepielewski MA, Rollin GA, Casagrande A, Ferreira NP. Czepielewski MA, et al. Among authors: casagrande a. Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1362-72. doi: 10.1590/s0004-27302007000800023. Arq Bras Endocrinol Metabol. 2007. PMID: 18209875 Review.
Long-Term Remission of Acromegaly after Octreotide Withdrawal Is an Uncommon and Frequently Unsustainable Event.
Casagrande A, Bronstein MD, Jallad RS, Moraes AB, Elias PC, Castro M, Czepielewski MA, Boschi A, Ribeiro-Oliveira A Jr, Schweizer JR, Vilar L, Nazato DM, Gadelha MR, Abucham J; all other investigators of the study. Casagrande A, et al. Neuroendocrinology. 2017;104(3):273-279. doi: 10.1159/000446542. Epub 2016 May 5. Neuroendocrinology. 2017. PMID: 27161443 Free article.
Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine.
Gadelha MR, Casagrande A, Strasburger CJ, Bidlingmaier M, Snyder PJ, Guitelman MA, Boguszewski CL, Buchfelder M, Shimon I, Raverot G, Tóth M, Mezősi E, Doknic M, Fan X, Clemmons D, Trainer PJ, Struthers RS, Krasner A, Biller BMK. Gadelha MR, et al. Among authors: casagrande a. J Clin Endocrinol Metab. 2024 Jun 3:dgae385. doi: 10.1210/clinem/dgae385. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38828555
109 results